These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6137336)

  • 1. The alteration of hepatic cytochrome P-450 subpopulations of phenobarbital-induced and uninduced rat by regioselective hepatotoxins.
    Gumbrecht JR; Franklin MR
    Drug Metab Dispos; 1983; 11(4):312-8. PubMed ID: 6137336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
    Pershing LK; Franklin MR
    Xenobiotica; 1982 Nov; 12(11):687-99. PubMed ID: 6984805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution by high-pressure liquid chromatography and partial characterization of multiple forms of cytochrome P-450 from hepatic microsomes of phenobarbital-treated rats.
    Bansal SK; Love JH; Gurtoo HL
    Eur J Biochem; 1985 Jan; 146(1):23-33. PubMed ID: 3917920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ethanol and benzene on cytochrome P-450 fractions in rat liver microsomes.
    Beaune P; Flinois JP; Le Provost E; Leroux JP
    Drug Metab Dispos; 1983; 11(5):499-506. PubMed ID: 6138238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic necrosis caused by halothane and hypoxia in phenobarbital-treated rats.
    Ross WT; Daggy BP; Cardell RR
    Anesthesiology; 1979 Oct; 51(4):327-33. PubMed ID: 484894
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM; Franklin MR
    Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro spectral alteration of hepatic cytochrome P-450 by experimental drug injury.
    Willson RA; Hart FE
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):605-21. PubMed ID: 897349
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical localization of cytochrome P-450a in liver sections from untreated rats and rats treated with phenobarbital or 3-methylcholanthrene.
    Moody DE; Taylor LA; Smuckler EA; Levin W; Thomas PE
    Drug Metab Dispos; 1983; 11(4):339-43. PubMed ID: 6137340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytochrome P-450 in a selective subpopulation of hepatocytes.
    Gumucio JJ; DeMason LJ; Miller DL; Krezoski SO; Keener M
    Am J Physiol; 1978 Mar; 234(3):C102-9. PubMed ID: 629331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of cytochrome P-450 and b5 in hepatocyte subpopulations with phenobarbital].
    Panin LE; Usynin IF
    Biull Eksp Biol Med; 1986 Jun; 101(6):695-7. PubMed ID: 3730555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
    Belinsky SA; Kauffman FC; Thurman RG
    Mol Pharmacol; 1984 Nov; 26(3):574-81. PubMed ID: 6333582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
    Ng SF; Waxman DJ
    Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphenyl metabolism by rat liver microsomes: regioselective effects of inducers, inhibitors, and solvents.
    Haugen DA
    Drug Metab Dispos; 1981; 9(3):212-8. PubMed ID: 6113928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative characteristics of isolated forms of cytochrome P-450 induced by phenobarbital and perfluorodecalin].
    Grishanova AIu; Gutkina NI; Mishin VM
    Biokhimiia; 1988 Mar; 53(3):368-76. PubMed ID: 3132207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of the liver monooxygenase system after induction with phenobarbital in the early neonatal period].
    Guliaeva LF; Mishin VM
    Vopr Med Khim; 1985; 31(5):49-53. PubMed ID: 3937330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.